HPG-0031

N/A

Report date: 2025/04/24 17:43:11

Base Information

Drug NameHPG-0031

Drug Alias Nameantisense morpholino oligomer-cell penetrating peptide conjugate (PYC Therapeutics)HPG-0031

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Peptide-oligonucleotide ConjugateSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) > Peptide-oligonucleotide Conjugate

Mechanisms of ActionAntisense oligonucleotide inhibitors

TargetsUpdating

Therapy Area/IndicationsRetinal DiseasesEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesPYC Therapeutics LLC

China Registration ClassN/A

Develop Information

Active CompaniesPYC Therapeutics LLC

Inactive CompaniesN/A

Active IndicationsRetinal Diseases

Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A